Internal Medicine, Cardiovascular Disease · Rochester, NY
NPI
1194356857
Since 2020
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
1415 Portland Ave Ste 350
Rochester, NY, 14621
Phone (585) 442-5320
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,721
200 services
Medicare patients, 2024
78
Average age 72
Drug cost, 2024
$2.2M
2,335 prescriptions
Company payments, 2025
$12K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lyudmila Kuchma was code 99214 (office e&m - established), 103 times for 71 patients. In total Lyudmila Kuchma billed 200 services in 6 codes, and Medicare paid $7,721.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 103 | 71 | $62.91 | $6,480 |
| 93010 Electrocardiogram | Facility | 54 | 41 | $5.34 | $289 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 32 | 25 | $11.33 | $363 |
By year: 2022 $5,139 for 123 services; 2023 $5,067 for 111 services; 2024 $7,721 for 200 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lyudmila Kuchma prescribed most often to Medicare patients was Metoprolol Succinate, with 259 prescriptions and refills. In total Lyudmila Kuchma wrote 2,335 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 259 | 644 | 113 | $4,575 |
| Atorvastatin Calcium Generic | 196 | 539 | 84 | $2,798 |
| Camzyos Mavacamten | 184 | 184 | 30 | $1.5M |
| Amlodipine Besylate Generic | 176 | 425 | 67 | $1,117 |
| Ezetimibe Generic | 115 | 246 | 42 | $3,435 |
| Carvedilol Generic | 110 | 200 | 37 | $784 |
| Eliquis Apixaban | 108 | 184 | 32 | $102K |
| Losartan Potassium Generic | 89 | 229 | 44 | $1,085 |
| Furosemide Generic | 88 | 176 | 43 | $416 |
| Entresto Sacubitril/Valsartan | 84 | 108 | 20 | $64K |
| Spironolactone Generic | 78 | 177 | 35 | $527 |
| Rosuvastatin Calcium Generic | 66 | 157 | 25 | $1,685 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 61 | 153 | 27 | $1,594 |
| Metoprolol Tartrate Generic | 57 | 133 | 25 | $444 |
| Torsemide Generic | 53 | 73 | 15 | $697 |
Brand drugs: 593 claims; generic drugs: 1,742 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lyudmila Kuchma $12K ($12K in general payments such as food, travel and fees) from 12 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $11K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 29 | $11K |
| Boston Scientific Corporation BSX | 1 | $153 |
| BridgeBio Pharma, Inc. BBIO | 3 | $151 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $148 |
| Novo Nordisk Inc NVO | 2 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $115 |
| Lilly USA, LLC LLY | 1 | $104 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $91 |
| Amgen Inc. AMGN | 1 | $59.98 |
| Pfizer Inc. PFE | 3 | $55.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.